InvestorsObserver is giving Humanigen Inc (HGEN) an Analyst Rating Rank of 30, meaning HGEN is ranked higher by analysts than 30% of stocks. The average price target for HGEN is $19 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating HGEN a Buy today. Find out what this means to you and get the rest of the rankings on HGEN!
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Humanigen Inc Stock Today?
Humanigen Inc (HGEN) stock is higher by 2.72% while the S&P 500 has fallen -0.86% as of 12:14 PM on Thursday, Jun 30. HGEN is up $0.05 from the previous closing price of $1.84 on volume of 1,618,682 shares. Over the past year the S&P 500 has fallen -11.90% while HGEN has fallen -89.13%. HGEN lost -$3.18 per share the over the last 12 months.
Click Here to get the full Stock Report for Humanigen Inc stock.